Boris Nikolic

Co-founded and currently leads a venture investing firm focused on healthcare and life sciences, raising significant capital for innovative biotech solutions. The firm specializes in identifying and funding disruptive technologies in areas like gene editing and digital health.

Oversees the firm's investment strategy, which includes identifying and funding over a dozen companies in gene editing and other health technologies since 2014. He leverages his scientific background to guide investment decisions.

Served as the principal scientific and technological advisor to Bill Gates, guiding strategic investments across various sectors, including global health and technology. This role involved leading select for-profit and philanthropic initiatives.

Conducted postdoctoral training and research at Harvard Medical School, focusing on complex areas such as immunogenetics and immunological tolerance. This research contributed to his deep expertise in the life sciences.

Completed medical training at the University of Zagreb, which provided a foundational understanding of clinical practice and human biology. This education is the basis for his later work in immunology and biotech investment.